EVERADS THERAPY
General Data
Reg Number
515541324
Sector
Medical Devices
Established
2017
No. of Employees
8
Stage
R&D
Additional Funding
0
Technology
Novel Delivery Device and Method for Delivery of Posterior Segment Retinal Therapeutics to the Suprachoroidal Space of the eye.
Targeted Customers
Pharma Companies, Physicians, Patients with retinal diseases.
Management personnel
Moshe Weinstein - CEO
Hagay Drori - CTO & COO
Yonatan Cohavi - CFO
Winning details
Route name
Winning year
R&D Program second/third year request for Entitled Growth Corporate
R&D Program second/third year request for Entitled Growth Corporate
2023
R&D Program second/third year request for Entitled Growth Corporate
R&D Program second/third year request for Entitled Growth Corporate
2023